Dr. Jessica T. Leonard
Claim this profileOregon Health and Science University
Studies Acute Lymphoblastic Leukemia
Studies Lymphoid Leukemia
6 reported clinical trials
11 drugs studied
Area of expertise
1Acute Lymphoblastic Leukemia
t(9;22) translocation positive
CD38 positive
Philadelphia chromosome positive
2Lymphoid Leukemia
t(9;22) translocation positive
CD38 positive
Philadelphia chromosome positive
Affiliated Hospitals
Clinical Trials Jessica T. Leonard is currently running
OBI-3424
for T-Cell Acute Lymphoblastic Leukemia
This phase II trial studies how well OBI-3424 works in treating patients with T-cell acute lymphoblastic leukemia that has come back (relapsed) or does not response to treatment (refractory). Drugs used in chemotherapy, such as OBI-3424, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. OBI-3424 may reduce the amount of leukemia in the body.
Recruiting1 award Phase 219 criteria
Inotuzumab + Blinatumomab
for Acute Lymphoblastic Leukemia
This phase II trial studies how well inotuzumab ozogamicin and blinatumomab work in treating patients with CD22-positive B-lineage acute lymphoblastic leukemia that is newly diagnosed, has come back, or does not respond to treatment. Immunotherapy with monoclonal antibodies, such as inotuzumab ozogamicin and blinatumomab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Recruiting1 award Phase 210 criteria
More about Jessica T. Leonard
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jessica T. Leonard has experience with
- Dasatinib
- Prednisone
- Rituximab
- Venetoclax
- XmAb18968
- Imatinib
Breakdown of trials Jessica T. Leonard has run
Acute Lymphoblastic Leukemia
Lymphoid Leukemia
T-Lymphoblastic Leukemia/Lymphoma
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jessica T. Leonard specialize in?
Jessica T. Leonard focuses on Acute Lymphoblastic Leukemia and Lymphoid Leukemia. In particular, much of their work with Acute Lymphoblastic Leukemia has involved t(9;22) translocation positive patients, or patients who are CD38 positive.
Is Jessica T. Leonard currently recruiting for clinical trials?
Yes, Jessica T. Leonard is currently recruiting for 4 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Jessica T. Leonard has studied deeply?
Yes, Jessica T. Leonard has studied treatments such as Dasatinib, Prednisone, Rituximab.
What is the best way to schedule an appointment with Jessica T. Leonard?
Apply for one of the trials that Jessica T. Leonard is conducting.
What is the office address of Jessica T. Leonard?
The office of Jessica T. Leonard is located at: Oregon Health and Science University, Portland, Oregon 97239 United States. This is the address for their practice at the Oregon Health and Science University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.